Thomas Decaens

researcher

Born 1974-01-01

Thomas Decaens is …
instance of (P31):
humanQ5

External links are
P269IdRef ID077283465
P213ISNI0000000357106060
P496ORCID iD0000-0003-0928-0048
P1053ResearcherIDL-9483-2013
P214VIAF ID196013383

P184doctoral advisorSabine ColnotQ30512422
P735given nameThomasQ16428906
ThomasQ16428906
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q57756525A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
Q86844817ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway
Q60904398Activer un signal bêta-caténine dans le foie est oncogénique
Q45980006Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.
Q104560036Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals
Q61800031Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection
Q38342390Clinical trial watch: reports from the AASLD Liver Meeting®, Boston, November 2014.
Q51740036Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma.
Q40224423Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study.
Q48137167Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
Q48354879Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
Q38410139Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
Q88202976Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma
Q35925442Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.
Q42345365Hepatitis E Virus Infection after Platelet Transfusion in an Immunocompetent Trauma Patient.
Q53824769Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.
Q43948766Imaging benign hepatocellular tumors: atypical forms and diagnostic traps.
Q46971158Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
Q81881751Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma
Q43492530Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma.
Q24611474International network of cancer genome projects
Q38110741Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: are we only looking at tumor necrosis?
Q47396238Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives.
Q35531887Liver resection for hepatocellular carcinoma in 313 Western patients: tumor biology and underlying liver rather than tumor size drive prognosis.
Q33508431Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation
Q48341630Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance
Q83445257Non-invasive diagnostic imaging of hepatocellular carcinoma: targeting cellular characterization?
Q38993647Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC.
Q36922108Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype
Q33928170Outcomes in adult recipients of right-sided liver grafts in split-liver procedures.
Q46582065PD-020Tolerability and activity of second-line tepotinib, a potent and highly selective c-MET inhibitor, in patients with advanced hepatocellular carcinoma previously treated with sorafenib
Q37259964Performance of bile aspiration plus brushing to diagnose malignant biliary strictures during endoscopic retrograde cholangiopancreatography.
Q48233798Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.
Q40124779Progression of fibrosis in patients with chronic viral hepatitis is associated with IL-17(+) neutrophils.
Q86909217Recurrence after liver transplantation for hepatocellular carcinoma according to up-to-seven criteria
Q40265226Recurring multicystic inflammatory pseudotumor of the liver: a case report.
Q33567122Sex Differences in Spontaneous Degranulation Activity of Intrahepatic Natural Killer Cells during Chronic Hepatitis B: Association with Estradiol Levels
Q48284910Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis.
Q53326694Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate.
Q26830194Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends
Q56384328Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
Q83739293Transplantation for liver failure in patients with sickle cell disease: challenging but feasible
Q41546596Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors.
Q60904389Voie Wnt/β-caténine et zonation métabolique du foie : un nouvel acteur pour un ancien concept
Q91337532[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]
Q53209403[Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen].
Q84393654[Liver transplantation for hepatocellular carcinoma and for patients with pre-existing cancers]

Q30512422Sabine Colnotdoctoral studentP185

Search more.